Norges Bank Immuno Gen, Inc. Transaction History

Norges Bank

  • $716 Trillion
  • Q3 2024

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024
BUY
$12.46 - $29.95 $69 Million - $166 Million
5,539,334 New
5,539,334 $164 Million
Q3 2023

Nov 13, 2024
BUY
$14.09 - $19.87 $29 Million - $40.8 Million
2,055,089 New
2,055,089 $32.6 Million
Q2 2023

Aug 14, 2024
BUY
$3.75 - $20.05 $618,750 - $3.31 Million
165,000 New
165,000 $3.11 Million
Q2 2023

Aug 14, 2023
SELL
$3.75 - $20.05 $430,875 - $2.3 Million
-114,900 Closed
0 $0
Q2 2022

Aug 14, 2023
BUY
$3.15 - $5.76 $361,935 - $661,824
114,900 New
114,900 $517,000
Q1 2022

May 12, 2023
BUY
$4.26 - $7.48 $8.24 Million - $14.5 Million
1,934,900 New
1,934,900 $9.21 Million
Q1 2022

May 09, 2022
SELL
$4.26 - $7.48 $8.24 Million - $14.5 Million
-1,934,900 Closed
0 $0
Q4 2021

Mar 09, 2022
BUY
$4.75 - $7.5 $9.19 Million - $14.5 Million
1,934,900 New
1,934,900 $14.4 Million
Q3 2020

Nov 10, 2020
SELL
$3.45 - $4.89 $2.28 Million - $3.24 Million
-661,600 Closed
0 $0
Q2 2020

Aug 13, 2021
BUY
$3.32 - $5.34 $2.2 Million - $3.53 Million
661,600 New
661,600 $3.04 Million
Q4 2019

Feb 12, 2020
SELL
$2.25 - $5.8 $521,442 - $1.34 Million
-231,752 Closed
0 $0
Q3 2019

Nov 13, 2020
BUY
$2.22 - $3.39 $514,489 - $785,639
231,752 New
231,752 $561,000
Q3 2019

Nov 08, 2019
SELL
$2.22 - $3.39 $514,489 - $785,639
-231,752 Closed
0 $0
Q2 2019

Aug 13, 2020
BUY
$1.8 - $3.3 $417,153 - $764,781
231,752 New
231,752 $503,000
Q2 2019

Aug 09, 2019
SELL
$1.8 - $3.3 $771,089 - $1.41 Million
-428,383 Closed
0 $0
Q4 2018

Mar 04, 2019
BUY
$3.94 - $9.7 $1.69 Million - $4.16 Million
428,383 New
428,383 $2.06 Million
Q4 2018

Feb 08, 2019
SELL
$3.94 - $9.7 $2.1 Million - $5.18 Million
-533,979 Closed
0 $0
Q3 2018

Nov 12, 2019
BUY
$8.6 - $11.26 $4.59 Million - $6.01 Million
533,979 New
533,979 $5.06 Million
Q3 2018

Nov 09, 2018
SELL
$8.6 - $11.26 $4.59 Million - $6.01 Million
-533,979 Closed
0 $0
Q2 2018

Aug 12, 2019
BUY
$9.52 - $12.15 $5.08 Million - $6.49 Million
533,979 New
533,979 $5.2 Million
Q2 2018

Jul 23, 2018
SELL
$9.52 - $12.15 $3.18 Million - $4.06 Million
-333,979 Closed
0 $0
Q1 2018

May 15, 2019
BUY
$6.7 - $12.95 $2.24 Million - $4.33 Million
333,979 New
333,979 $3.51 Million
Q1 2018

May 09, 2018
SELL
$6.7 - $12.95 $2.24 Million - $4.33 Million
-333,979 Closed
0 $0
Q4 2017

Mar 05, 2018
BUY
$5.07 - $7.92 $1.69 Million - $2.65 Million
333,979 New
333,979 $2.14 Million
Q4 2017

Feb 09, 2018
SELL
$5.07 - $7.92 $1.69 Million - $2.65 Million
-333,979 Closed
0 $0
Q3 2017

Nov 13, 2018
BUY
$5.4 - $8.47 $1.8 Million - $2.83 Million
333,979 New
333,979 $2.56 Million
Q3 2017

Nov 07, 2017
SELL
$5.4 - $8.47 $1.8 Million - $2.83 Million
-333,979 Closed
0 $0
Q2 2017

Jul 24, 2018
SELL
N/A
-1,196,793 Reduced 78.18%
333,979 $2.38 Million
Q3 2016

Nov 13, 2017
BUY
N/A
1,530,772
1,530,772 $0

Others Institutions Holding IMGN

# of Institutions
8
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Norges Bank Portfolio

Follow Norges Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email